Search Result

Results for "

deuterated form

" in MedChemExpress (MCE) Product Catalog:

By Targets:	5-HT Receptor (1) ADC Payload (2) Adenosine Receptor (1) Akt (1) Apoptosis (1) Arginase (1) Autophagy (1) Bacterial (1) Biochemical Assay Reagents (2) Cholinesterase (ChE) (1) Disulfidptosis (3) Dopamine Transporter (1) Drug Metabolite (1) Endogenous Metabolite (3) ERK (1) Estrogen Receptor/ERR (1) Histone Methyltransferase (1) HMG-CoA Reductase (HMGCR) (1) Insecticide (1) Interleukin Related (1) Isotope-Labeled Compounds (26) Keap1-Nrf2 (1) Microtubule/Tubulin (2) Mitochondrial Metabolism (3) MMP (1) nAChR (1) Neurokinin Receptor (1) Parasite (1) Potassium Channel (1) Reactive Oxygen Species (ROS) (2) Serotonin Transporter (1) Thyroid Hormone Receptor (1) TNF Receptor (1) VD/VDR (3)
By Research Areas:	Cancer (10) Cardiovascular Disease (1) Endocrinology (2) Infection (3) Inflammation/Immunology (3) Metabolic Disease (8) Neurological Disease (6)

By Targets:

5-HT Receptor (1)

ADC Payload (2)

Adenosine Receptor (1)

Akt (1)

Apoptosis (1)

Arginase (1)

Autophagy (1)

Bacterial (1)

Biochemical Assay Reagents (2)

Cholinesterase (ChE) (1)

Disulfidptosis (3)

Dopamine Transporter (1)

Drug Metabolite (1)

Endogenous Metabolite (3)

ERK (1)

Estrogen Receptor/ERR (1)

Histone Methyltransferase (1)

HMG-CoA Reductase (HMGCR) (1)

Insecticide (1)

Interleukin Related (1)

Isotope-Labeled Compounds (26)

Keap1-Nrf2 (1)

Microtubule/Tubulin (2)

Mitochondrial Metabolism (3)

MMP (1)

nAChR (1)

Neurokinin Receptor (1)

Parasite (1)

Potassium Channel (1)

Reactive Oxygen Species (ROS) (2)

Serotonin Transporter (1)

Thyroid Hormone Receptor (1)

TNF Receptor (1)

VD/VDR (3)

By Research Areas:

Cancer (10)

Cardiovascular Disease (1)

Endocrinology (2)

Infection (3)

Inflammation/Immunology (3)

Metabolic Disease (8)

Neurological Disease (6)

Inhibitors & Agonists

Isotope-Labeled Compounds

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-I1124

L-Valine-d8 1 Publications Verification L-VALINE-2,3,4,4,4,5,5,5-d₈	Isotope-Labeled Compounds Arginase Akt Bacterial	Infection
L-Valine-d₈ is a deuterated form of L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-W050026S

Phenylacetylglutamine-d5 2 Publications Verification NSC 203800-d₅; Phenylacetyl-L-glutamine-d₅	Endogenous Metabolite Isotope-Labeled Compounds	Others
Phenylacetylglutamine-d₅ (NSC 203800-d₅) is the deuterium labeled Phenylacetylglutamine (HY-W050026). Phenylacetylglutamine is a colonic microbial metabolite from amino acid fermentation .

HY-15579AS

MMAF-d8 hydrochloride 1 Publications Verification	Microtubule/Tubulin ADC Payload	Cancer
MMAF-d₈ (hydrochloride)e is a deuterated form of MMAF hydrochloride, which is a microtubule disrupting agent.

HY-B0263S

Thiabendazole-d4 2-(4-Thiazolyl)benzimidazole-d₄	Mitochondrial Metabolism Parasite	Others
Thiabendazole-d₄ is a deuterated form of Thiabendazole, which is an antiseptic, antifungal and antiparasitic agent .

HY-12766S

Bupropion morpholinol-d6	Isotope-Labeled Compounds nAChR Dopamine Transporter	Neurological Disease
Bupropion morpholinol-d6 is the deuterated form of Bupropion morpholinol. Bupropion morpholinol is a major metabolite of Bupropion. Bupropion morpholinol inhibits Dopamine, Norepinephrine transporters and the α4β2 nicotinic receptor in vitro. Bupropion morpholinol contributes to antidepressant and smoking cessation activities .

HY-114299S

Salcaprozate-d4 sodium SNAC-d4 sodium	Isotope-Labeled Compounds	Others
Salcaprozate-d4 (sodium) is a deuterated labeled Salcaprozate (sodium) . Salcaprozate sodium (SNAC), an oral absorption promoter, and has the potential as a delivery agent for oral forms of heparin and insulin. Salcaprozate sodium could increase passive transcellular permeation across small intestinal epithelia based on increased lipophilicity arising from non-covalent macromolecule complexation .

HY-15917S2

DL-Dithiothreitol-d6 DTT-d₆	Isotope-Labeled Compounds Disulfidptosis	Cancer
DL-Dithiothreitol-d₆ is the deuterated form of DL-Dithiothreitol. DL-dithiothreitol (DTT) is a strong reductant with anti-disulfidptosis activity. DL-dithiothreitol is oxidized to form a stable six-membered ring with an internal disulfide bond .

HY-P3003S

Cereulide-13C6	Isotope-Labeled Compounds Apoptosis Potassium Channel Mitochondrial Metabolism Autophagy Reactive Oxygen Species (ROS)	Infection Neurological Disease Metabolic Disease Inflammation/Immunology
Cereulide- ¹³C₆ is a deuterated form of Cereulide. Cereulide is an orally active, blood-brain barrier-permeable emetic toxin. Cereulide acts as a potassium ionophore that inserts into membranes, forms complexes with K ⁺, and transports K ⁺ from the cytoplasm into the mitochondrial matrix. Cereulide disrupts the electrochemical gradient of the inner mitochondrial membrane, leading to mitochondrial swelling and dysfunction, uncoupling of oxidative phosphorylation, inhibition of ATP synthesis, ROS accumulation, and ultimately triggering apoptosis and autophagy. Cereulide exhibits multi-organ toxicity and can be used for research on emetic food poisoning.

HY-W012382S

N-Acetyl-L-tyrosine-d3	Isotope-Labeled Compounds Endogenous Metabolite	Metabolic Disease Cancer
N-Acetyl-L-tyrosine-d₃ is the deuterated form of N-Acetyl-L-tyrosine (HY-W012382). N-Acetyl-L-tyrosine is an orally active endogenous mitochondrial stress response regulator that can permeate the cell membrane by passive diffusion. N-Acetyl-L-tyrosine induces low-level reactive oxygen species (ROS) generation by transiently perturbing mitochondrial membrane potential, triggering reverse signaling to activate FoxO and Keap1 pathways. As a result, N-Acetyl-L-tyrosine enhances the expression of antioxidant enzyme genes, exerting anti-stress and cytoprotective effects. N-Acetyl-L-tyrosine can improve heat stress tolerance, inhibit tumor growth, and regulate energy metabolism. N-Acetyl-L-tyrosine can be used in the research of aging, metabolic diseases (such as diabetes), and cancer .

HY-A0070AS3

Liothyronine-d3 Triiodothyronine-d₃; 3,3',5-Triiodo-L-thyronine-d₃; T3-d₃	Endogenous Metabolite Thyroid Hormone Receptor Isotope-Labeled Compounds	Endocrinology Cancer
Liothyronine-d₃ is deuterated labeled Liothyronine (HY-A0070A). Liothyronine is an active form of thyroid hormone. Liothyronine is a potent thyroid hormone receptors TRα and TRβ agonist with K_is of 2.33 nM for hTRα and hTRβ, respectively .

HY-15917S

DL-Dithiothreitol-d10 DTT-d₁₀	Isotope-Labeled Compounds Disulfidptosis	Cancer
DL-Dithiothreitol-d₁₀ is the deuterated form of DL-Dithiothreitol. DL-Dithiothreitol (DTT) is a strong reductant with anti-disulfidptosis activity. When DL-Dithiothreitol is oxidized, it forms a stable six-membered ring with an internal disulfide bond .

HY-101873S

Atorvastatin lactone-d5	Isotope-Labeled Compounds HMG-CoA Reductase (HMGCR)	Metabolic Disease Inflammation/Immunology
Atorvastatin lactone-d₅ is a deuterated form of Atorvastatin lactone (HY-101873). Atorvastatin lactone is a proagent form of atorvastatin. Atorvastatin is an orally active 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor .

HY-W011038S

Hexadecylpyridinium-d5 bromide HDPB-d₅	Isotope-Labeled Compounds Biochemical Assay Reagents	Others
Hexadecylpyridinium bromide-d₅ (HDPB-d₅) is the deuterated form of Hexadecylpyridinium bromide. Hexadecylpyridinium bromide (HDPB) is a cationic surfactant. Hexadecylpyridinium bromide can act as a sensitizer and solubilizer, and is a key component in spectrophotometric determination of metal ion reaction systems. Hexadecylpyridinium bromide can be used as a new passivating ligand for the synthesis and stabilization of cesium lead bromide calcium phosphate nanocrystals.

HY-15414AS

Vortioxetine-d8 hydrobromide Lu AA21004-d8 hydrobromide	Isotope-Labeled Compounds 5-HT Receptor Serotonin Transporter	Neurological Disease
Vortioxetine-d₈ (Lu AA 21004-d₈) hydrobromide is the deuterated form of Vortioxetine. Vortioxetine (Lu AA 21004) is an antagonist of 5-HT_3A and 5-HT₇ receptors (K_i: 3.7 nM, 19 nM) and an inhibitor of 5-hydroxytryptamine transporter (SERT) (K_i: 1.6 nM), as well as a 5-HT_1A agonist and a partial 5-HT_1B agonist (K_i: 15 nM, 33 nM) .

HY-132494S

Perazine-d8	Isotope-Labeled Compounds	Others
Perazine-d₈ is a deuterated form of Perazine. Perazine is a potent and orally active antidepressant agent. Perazine has the potential for the research of acute schizophrenics .

HY-B0916S

Propoxur-d3	Isotope-Labeled Compounds Insecticide Cholinesterase (ChE) MMP Reactive Oxygen Species (ROS) ERK Keap1-Nrf2	Infection Neurological Disease Cancer
Propoxur-d₃ is the deuterated form of Propoxur (HY-B0916). Propoxur is a reversible, competitive, orally active AChE inhibitor that can cross the blood-brain barrier. Propoxur inhibits AChE activity to induce neurotoxicity, while promoting MMP-2 expression and enhancing tumor cell migration and invasion by inducing intracellular ROS generation and activating the ERK/Nrf2 signaling pathway. On the one hand, Propoxur inhibits AChE, leading to acetylcholine accumulation and causing neurological dysfunction; on the other hand, it promotes Nrf2 nuclear translocation through ROS-dependent ERK1/2 phosphorylation, and upregulates MMP-2 and other invasion-related proteins. Propoxur is also a carbamate insecticide used to combat turf, forestry, and household pests .

HY-15581S

MMAD-d8 Demethyldolastatin 10-d₈; Monomethylauristatin D-d₈; Monomethyl Dolastatin 10-d₈	ADC Payload Microtubule/Tubulin	Cancer
MMAD-d₈D is a deuterated form of MMAD, which is a microtubule disrupting agent.

HY-15327

1alpha, 25-Dihydroxy VD2-d6	Isotope-Labeled Compounds VD/VDR	Metabolic Disease
1alpha, 25-Dihydroxy VD2-d₆6 is a deuterated form of vitamin D.

HY-15285

Doxercalciferol-d3	VD/VDR	Metabolic Disease
Doxercalciferol-d₃3 is the deuterated form of Doxercalciferol, which is a Vitamin D2 analog that acts as a vitamin D receptor activator (VDRA).

HY-W354544

(Rac)-Hexestrol Dihydrodiethylstilbestrol	Estrogen Receptor/ERR	Endocrinology
(Rac)-Hexestrol is the racemic form of Hexestrol (HY-B1662). Hexestrol is a synthetic non-steroidal estrogen. (Rac)-Hexestrol usually appears in deuterated form and is used as an internal standard for precise quantitative analysis in analytical chemistry.

HY-15917S1

DL-Dithiothreitol-d10-1 DTTl-d₁₀-1	Isotope-Labeled Compounds Disulfidptosis	Cancer
DL-Dithiothreitol-d₁₀-1 is the deuterated form of DL-dithiothreitol. DL-Dithiothreitol (DTT) is a strong reductant with anti-disulfidptosis activity. DL-Dithiothreitol is oxidized to form a stable six-membered ring with an internal disulfide bond .

HY-15329

Maxacalcitol-d6	VD/VDR	Metabolic Disease
Maxacalcitol-d₆6 is the deuterated form of Maxacalcitol (22-Oxacalcitriol), which is a non-calcemic vitamin D3 analog and VDR ligand of VDR-like receptors.

HY-60351S

5-Aminopyrimidine-d3	Isotope-Labeled Compounds Biochemical Assay Reagents	Others
5-Aminopyrimidine-d₃ is the deuterated form of 5-Aminopyrimidine. 5-Aminopyrimidine is a biochemical reagent that can serve as a biomaterial or an organic compound for research related to life sciences. Its derivatives exhibit antioxidant activity .

HY-W007692S

Acetylpyrazine-d3 2-Acetylpyrazine-d₃	Isotope-Labeled Compounds	Others
Acetylpyrazine-d₃ is deuterated labeled Acetylpyrazine (HY-W007692). Acetylpyrazine (2-Acetylpyrazine) is used to form many polycyclic compounds, as useful structures in pharmaceuticals and perfumes. Acetylpyrazine is a component of the folates (vitamin B compounds) .

HY-19532S

ZM241385-d7	Isotope-Labeled Compounds Adenosine Receptor	Neurological Disease Cancer
ZM241385-d7 is a deuterated form of ZM241385 (HY-19532). ZM241385 is a potent, high affinity and selective adenosine A_2a receptor (A_2AR) antagonist with a K_i value of 1.4 nM .

HY-163587

PRMT5-IN-39-d3	Histone Methyltransferase	Cancer
PRMT5-IN-39-d3 is the deuterated form of PRMT5-IN-39. PRMT5-IN-39-d3 is an orally active PRMT5 inhibitor and can be used for study of cancer .

HY-114360AS1

Taurohyodeoxycholic acid-d4 sodium	Isotope-Labeled Compounds TNF Receptor Interleukin Related	Inflammation/Immunology
Taurohyodeoxycholic acid-d4 (sodium) is a deuterated labeled Taurohyodeoxycholic acid (sodium) . Taurohyodeoxycholic acid (THDCA) sodium is the taurine-conjugated form of the secondary bile acid hyodeoxycholic acid. Taurohyodeoxycholic acid can also reduce the activity and expression of myeloperoxidase TNF-α and IL-6, as well as colonic damage in TNBS-induced ulcerative colitis mouse model.

HY-B1836S

Meldonium-d3 MET-88-d₃; Quaterin-d₃	Isotope-Labeled Compounds Mitochondrial Metabolism	Cardiovascular Disease Metabolic Disease
Meldonium-d3 is the deuterated form of Meldonium. Meldonium is a cardiovascular protective agent that competitively inhibits BBOX1 and OCTN2. The IC₅₀ value of Mildronate against human recombinant BBOX is 34-62 μM, and the EC₅₀ value against human OCTN2 is 21 μM. Meldonium is a fatty acid oxidation inhibitor .

HY-W020658S

18:0 PI-d6 DSPI (18:0/18:0)-d₆	Isotope-Labeled Compounds	Metabolic Disease
18:0 PI-d₆ (DSPI(18:0/18:0)-d₆) is the deuterated form of 18:0 PI. 18:0 PI is a membrane-bound signaling molecule that is associated with almost all aspects of cell physiology, including cell growth, metabolism, proliferation, and survival .

HY-W757743

Acalabrutinib-d3 ACP-196-d₃	Isotope-Labeled Compounds	Others
Acalabrutinib-d₃ (ACP-196-d₃) is the deuterated form of Acalabrutinib (HY-17600). Acalabrutinib (ACP-196) is an orally active, irreversible, highly selective second-generation BTK inhibitor. Acalabrutinib covalently binds to Cys481 in the ATP-binding pocket of BTK. Acalabrutinib shows strong targeting and efficacy in mouse models of chronic lymphocytic leukemia (CLL).

HY-12142S

rac-Vofopitant-d3 rac-GR 205171-d₃	Isotope-Labeled Compounds Neurokinin Receptor	Neurological Disease
rac-Vofopitant-d₃ (rac-GR 205171-d₃) is a racemic form of deuterated Vofopitant (HY-12142). Vofopitant (GR 205171A) is a blood-brain barrier-permeable NK1 receptor inhibitor with a pKi of 9.02 in mice. Vofopitant blocks vomiting-related responses and inhibits pseudoptyalism. Vofopitant exerts anxiolytic effects, regulates 5-HT receptor function and increases central 5-HT release. Vofopitant improves hyperarousal symptoms of post-traumatic stress disorder. Vofopitant can be used in research related to depression, anxiety, vomiting and postoperative nausea and vomiting .

HY-146841S

Lysophosphatidylcholine C19:0-d5 1-Nonadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine-d₅; 19:0 Lyso PC-d₅	Isotope-Labeled Compounds	Others
Lecithin-cholesterol acyltransferase C19:0-d₅ (19:0 lecithin-cholesterol acyltransferase-d₅) is the deuterated form of lecithin-cholesterol acyltransferase C19:0 (HY-154830). Lecithin-cholesterol acyltransferase C19:0 is a lysophosphatidylcholine with a fully saturated C19 acyl chain. When lecithin-cholesterol acyltransferase C19:0 is combined with LPS (HY-D1056), it can induce the secretion of IL-1β by human monocyte-derived dendritic cells. Lecithin-cholesterol acyltransferase C19:0 can reduce the survival rate of dendritic cells derived from monocytes.

HY-W020576S

Rivastigmine metabolite-d6 NAP 226-90-d₆	Isotope-Labeled Compounds Drug Metabolite	Others
Rivastigmine metabolite-d6 (NAP 226-90-d6) is a deuterated form of Rivastigmine metabolite. Rivastigmine metabolite (NAP 226-90) is a metabolite produced by the hydrolysis of Rivastigmine (HY-17368) . Rivastigmine metabolite serves as a surrogate marker to track the bioavailability, metabolic extent, and transdermal patch delivery rate of Rivastigmine .

Cat. No.	Product Name	Chemical Structure

HY-I1124

L-Valine-d8 1 Publications Verification
L-Valine-d₈ is a deuterated form of L-Valine (HY-N0717). L-Valine ((S)-Valine) is a nonlinear semiorganic material. L-Valine causes lipid peroxidation and accumulation of malondialdehyde (MDA), exhibits inhibitory activity against cyanobacteria. L-Valine inhibits multidrug-resistant bacteria through activation of PI3K/Akt signaling pathway and inhibition of arginase .

HY-W050026S

Phenylacetylglutamine-d5 2 Publications Verification
Phenylacetylglutamine-d₅ (NSC 203800-d₅) is the deuterium labeled Phenylacetylglutamine (HY-W050026). Phenylacetylglutamine is a colonic microbial metabolite from amino acid fermentation .

HY-15579AS

MMAF-d8 hydrochloride 1 Publications Verification
MMAF-d₈ (hydrochloride)e is a deuterated form of MMAF hydrochloride, which is a microtubule disrupting agent.

HY-B0263S

Thiabendazole-d4
Thiabendazole-d₄ is a deuterated form of Thiabendazole, which is an antiseptic, antifungal and antiparasitic agent .

HY-12766S

Bupropion morpholinol-d6
Bupropion morpholinol-d6 is the deuterated form of Bupropion morpholinol. Bupropion morpholinol is a major metabolite of Bupropion. Bupropion morpholinol inhibits Dopamine, Norepinephrine transporters and the α4β2 nicotinic receptor in vitro. Bupropion morpholinol contributes to antidepressant and smoking cessation activities .

HY-114299S

Salcaprozate-d4 sodium
Salcaprozate-d4 (sodium) is a deuterated labeled Salcaprozate (sodium) . Salcaprozate sodium (SNAC), an oral absorption promoter, and has the potential as a delivery agent for oral forms of heparin and insulin. Salcaprozate sodium could increase passive transcellular permeation across small intestinal epithelia based on increased lipophilicity arising from non-covalent macromolecule complexation .

Salcaprozate-d4 sodium

Salcaprozate-d4 (sodium) is a deuterated labeled Salcaprozate (sodium) . Salcaprozate sodium (SNAC), an oral absorption promoter, and has the potential as a delivery agent for oral forms of heparin and insulin. Salcaprozate sodium could increase passive transcellular permeation across small intestinal epithelia based on increased lipophilicity arising from non-covalent macromolecule complexation .

HY-15917S2

DL-Dithiothreitol-d6
DL-Dithiothreitol-d₆ is the deuterated form of DL-Dithiothreitol. DL-dithiothreitol (DTT) is a strong reductant with anti-disulfidptosis activity. DL-dithiothreitol is oxidized to form a stable six-membered ring with an internal disulfide bond .

HY-P3003S

Cereulide-13C6
Cereulide- ¹³C₆ is a deuterated form of Cereulide. Cereulide is an orally active, blood-brain barrier-permeable emetic toxin. Cereulide acts as a potassium ionophore that inserts into membranes, forms complexes with K ⁺, and transports K ⁺ from the cytoplasm into the mitochondrial matrix. Cereulide disrupts the electrochemical gradient of the inner mitochondrial membrane, leading to mitochondrial swelling and dysfunction, uncoupling of oxidative phosphorylation, inhibition of ATP synthesis, ROS accumulation, and ultimately triggering apoptosis and autophagy. Cereulide exhibits multi-organ toxicity and can be used for research on emetic food poisoning.

Cereulide-13C6

Cereulide- ¹³C₆ is a deuterated form of Cereulide. Cereulide is an orally active, blood-brain barrier-permeable emetic toxin. Cereulide acts as a potassium ionophore that inserts into membranes, forms complexes with K ⁺, and transports K ⁺ from the cytoplasm into the mitochondrial matrix. Cereulide disrupts the electrochemical gradient of the inner mitochondrial membrane, leading to mitochondrial swelling and dysfunction, uncoupling of oxidative phosphorylation, inhibition of ATP synthesis, ROS accumulation, and ultimately triggering apoptosis and autophagy. Cereulide exhibits multi-organ toxicity and can be used for research on emetic food poisoning.

HY-W012382S

N-Acetyl-L-tyrosine-d3
N-Acetyl-L-tyrosine-d₃ is the deuterated form of N-Acetyl-L-tyrosine (HY-W012382). N-Acetyl-L-tyrosine is an orally active endogenous mitochondrial stress response regulator that can permeate the cell membrane by passive diffusion. N-Acetyl-L-tyrosine induces low-level reactive oxygen species (ROS) generation by transiently perturbing mitochondrial membrane potential, triggering reverse signaling to activate FoxO and Keap1 pathways. As a result, N-Acetyl-L-tyrosine enhances the expression of antioxidant enzyme genes, exerting anti-stress and cytoprotective effects. N-Acetyl-L-tyrosine can improve heat stress tolerance, inhibit tumor growth, and regulate energy metabolism. N-Acetyl-L-tyrosine can be used in the research of aging, metabolic diseases (such as diabetes), and cancer .

N-Acetyl-L-tyrosine-d3

N-Acetyl-L-tyrosine-d₃ is the deuterated form of N-Acetyl-L-tyrosine (HY-W012382). N-Acetyl-L-tyrosine is an orally active endogenous mitochondrial stress response regulator that can permeate the cell membrane by passive diffusion. N-Acetyl-L-tyrosine induces low-level reactive oxygen species (ROS) generation by transiently perturbing mitochondrial membrane potential, triggering reverse signaling to activate FoxO and Keap1 pathways. As a result, N-Acetyl-L-tyrosine enhances the expression of antioxidant enzyme genes, exerting anti-stress and cytoprotective effects. N-Acetyl-L-tyrosine can improve heat stress tolerance, inhibit tumor growth, and regulate energy metabolism. N-Acetyl-L-tyrosine can be used in the research of aging, metabolic diseases (such as diabetes), and cancer .

HY-A0070AS3

Liothyronine-d3
Liothyronine-d₃ is deuterated labeled Liothyronine (HY-A0070A). Liothyronine is an active form of thyroid hormone. Liothyronine is a potent thyroid hormone receptors TRα and TRβ agonist with K_is of 2.33 nM for hTRα and hTRβ, respectively .

HY-15917S

DL-Dithiothreitol-d10
DL-Dithiothreitol-d₁₀ is the deuterated form of DL-Dithiothreitol. DL-Dithiothreitol (DTT) is a strong reductant with anti-disulfidptosis activity. When DL-Dithiothreitol is oxidized, it forms a stable six-membered ring with an internal disulfide bond .

HY-101873S

Atorvastatin lactone-d5
Atorvastatin lactone-d₅ is a deuterated form of Atorvastatin lactone (HY-101873). Atorvastatin lactone is a proagent form of atorvastatin. Atorvastatin is an orally active 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor .

HY-W011038S

Hexadecylpyridinium-d5 bromide

Hexadecylpyridinium bromide-d₅ (HDPB-d₅) is the deuterated form of Hexadecylpyridinium bromide. Hexadecylpyridinium bromide (HDPB) is a cationic surfactant. Hexadecylpyridinium bromide can act as a sensitizer and solubilizer, and is a key component in spectrophotometric determination of metal ion reaction systems. Hexadecylpyridinium bromide can be used as a new passivating ligand for the synthesis and stabilization of cesium lead bromide calcium phosphate nanocrystals.

HY-15414AS

Vortioxetine-d8 hydrobromide
Vortioxetine-d₈ (Lu AA 21004-d₈) hydrobromide is the deuterated form of Vortioxetine. Vortioxetine (Lu AA 21004) is an antagonist of 5-HT_3A and 5-HT₇ receptors (K_i: 3.7 nM, 19 nM) and an inhibitor of 5-hydroxytryptamine transporter (SERT) (K_i: 1.6 nM), as well as a 5-HT_1A agonist and a partial 5-HT_1B agonist (K_i: 15 nM, 33 nM) .

HY-132494S

Perazine-d8
Perazine-d₈ is a deuterated form of Perazine. Perazine is a potent and orally active antidepressant agent. Perazine has the potential for the research of acute schizophrenics .

HY-B0916S

Propoxur-d3

Propoxur-d₃ is the deuterated form of Propoxur (HY-B0916). Propoxur is a reversible, competitive, orally active AChE inhibitor that can cross the blood-brain barrier. Propoxur inhibits AChE activity to induce neurotoxicity, while promoting MMP-2 expression and enhancing tumor cell migration and invasion by inducing intracellular ROS generation and activating the ERK/Nrf2 signaling pathway. On the one hand, Propoxur inhibits AChE, leading to acetylcholine accumulation and causing neurological dysfunction; on the other hand, it promotes Nrf2 nuclear translocation through ROS-dependent ERK1/2 phosphorylation, and upregulates MMP-2 and other invasion-related proteins. Propoxur is also a carbamate insecticide used to combat turf, forestry, and household pests .

HY-15581S

MMAD-d8
MMAD-d₈D is a deuterated form of MMAD, which is a microtubule disrupting agent.

HY-15327

1alpha, 25-Dihydroxy VD2-d6
1alpha, 25-Dihydroxy VD2-d₆6 is a deuterated form of vitamin D.

HY-15285

Doxercalciferol-d3
Doxercalciferol-d₃3 is the deuterated form of Doxercalciferol, which is a Vitamin D2 analog that acts as a vitamin D receptor activator (VDRA).

HY-15917S1

DL-Dithiothreitol-d10-1
DL-Dithiothreitol-d₁₀-1 is the deuterated form of DL-dithiothreitol. DL-Dithiothreitol (DTT) is a strong reductant with anti-disulfidptosis activity. DL-Dithiothreitol is oxidized to form a stable six-membered ring with an internal disulfide bond .

HY-15329

Maxacalcitol-d6
Maxacalcitol-d₆6 is the deuterated form of Maxacalcitol (22-Oxacalcitriol), which is a non-calcemic vitamin D3 analog and VDR ligand of VDR-like receptors.

HY-60351S

5-Aminopyrimidine-d3
5-Aminopyrimidine-d₃ is the deuterated form of 5-Aminopyrimidine. 5-Aminopyrimidine is a biochemical reagent that can serve as a biomaterial or an organic compound for research related to life sciences. Its derivatives exhibit antioxidant activity .

HY-W007692S

Acetylpyrazine-d3
Acetylpyrazine-d₃ is deuterated labeled Acetylpyrazine (HY-W007692). Acetylpyrazine (2-Acetylpyrazine) is used to form many polycyclic compounds, as useful structures in pharmaceuticals and perfumes. Acetylpyrazine is a component of the folates (vitamin B compounds) .

HY-19532S

ZM241385-d7
ZM241385-d7 is a deuterated form of ZM241385 (HY-19532). ZM241385 is a potent, high affinity and selective adenosine A_2a receptor (A_2AR) antagonist with a K_i value of 1.4 nM .

HY-163587

PRMT5-IN-39-d3
PRMT5-IN-39-d3 is the deuterated form of PRMT5-IN-39. PRMT5-IN-39-d3 is an orally active PRMT5 inhibitor and can be used for study of cancer .

HY-114360AS1

Taurohyodeoxycholic acid-d4 sodium
Taurohyodeoxycholic acid-d4 (sodium) is a deuterated labeled Taurohyodeoxycholic acid (sodium) . Taurohyodeoxycholic acid (THDCA) sodium is the taurine-conjugated form of the secondary bile acid hyodeoxycholic acid. Taurohyodeoxycholic acid can also reduce the activity and expression of myeloperoxidase TNF-α and IL-6, as well as colonic damage in TNBS-induced ulcerative colitis mouse model.

HY-B1836S

Meldonium-d3
Meldonium-d3 is the deuterated form of Meldonium. Meldonium is a cardiovascular protective agent that competitively inhibits BBOX1 and OCTN2. The IC₅₀ value of Mildronate against human recombinant BBOX is 34-62 μM, and the EC₅₀ value against human OCTN2 is 21 μM. Meldonium is a fatty acid oxidation inhibitor .

HY-W020658S

18:0 PI-d6
18:0 PI-d₆ (DSPI(18:0/18:0)-d₆) is the deuterated form of 18:0 PI. 18:0 PI is a membrane-bound signaling molecule that is associated with almost all aspects of cell physiology, including cell growth, metabolism, proliferation, and survival .

HY-W757743

Acalabrutinib-d3
Acalabrutinib-d₃ (ACP-196-d₃) is the deuterated form of Acalabrutinib (HY-17600). Acalabrutinib (ACP-196) is an orally active, irreversible, highly selective second-generation BTK inhibitor. Acalabrutinib covalently binds to Cys481 in the ATP-binding pocket of BTK. Acalabrutinib shows strong targeting and efficacy in mouse models of chronic lymphocytic leukemia (CLL).

HY-12142S

rac-Vofopitant-d3

rac-Vofopitant-d₃ (rac-GR 205171-d₃) is a racemic form of deuterated Vofopitant (HY-12142). Vofopitant (GR 205171A) is a blood-brain barrier-permeable NK1 receptor inhibitor with a pKi of 9.02 in mice. Vofopitant blocks vomiting-related responses and inhibits pseudoptyalism. Vofopitant exerts anxiolytic effects, regulates 5-HT receptor function and increases central 5-HT release. Vofopitant improves hyperarousal symptoms of post-traumatic stress disorder. Vofopitant can be used in research related to depression, anxiety, vomiting and postoperative nausea and vomiting .

HY-146841S

Lysophosphatidylcholine C19:0-d5

Lecithin-cholesterol acyltransferase C19:0-d₅ (19:0 lecithin-cholesterol acyltransferase-d₅) is the deuterated form of lecithin-cholesterol acyltransferase C19:0 (HY-154830). Lecithin-cholesterol acyltransferase C19:0 is a lysophosphatidylcholine with a fully saturated C19 acyl chain. When lecithin-cholesterol acyltransferase C19:0 is combined with LPS (HY-D1056), it can induce the secretion of IL-1β by human monocyte-derived dendritic cells. Lecithin-cholesterol acyltransferase C19:0 can reduce the survival rate of dendritic cells derived from monocytes.

HY-W020576S

Rivastigmine metabolite-d6
Rivastigmine metabolite-d6 (NAP 226-90-d6) is a deuterated form of Rivastigmine metabolite. Rivastigmine metabolite (NAP 226-90) is a metabolite produced by the hydrolysis of Rivastigmine (HY-17368) . Rivastigmine metabolite serves as a surrogate marker to track the bioavailability, metabolic extent, and transdermal patch delivery rate of Rivastigmine .

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: